Novavax Inc (NVAX) SEC Filings — 2025
22 SEC filings for Novavax Inc (NVAX) in 2025.
Filings
- Novavax Files 8-K on Financials — 8-K · Nov 6, 2025
- Novavax Files 8-K Report — 8-K · Nov 4, 2025
- Novavax Files 8-K: Material Agreements and Impairments — 8-K · Oct 22, 2025
- Novavax Files 8-K: Regulation FD, Other Events, Financials — 8-K · Oct 7, 2025
- Novavax Files 8-K Report — 8-K · Aug 27, 2025
- Novavax Files 8-K: Material Agreement, Equity Sales — 8-K · Aug 21, 2025
- Novavax Q2 Revenue Plummets 92.8% Amid Fading Vaccine Demand — 10-Q · Aug 6, 2025
- Novavax Files 8-K on Security Holder Vote Matters — 8-K · Jun 24, 2025
- Novavax Inc 8-K Filing — 8-K · Jun 11, 2025
- Novavax Announces Board and Executive Changes — 8-K · May 27, 2025
- Novavax Files 8-K: Regulation FD Disclosure & Other Events — 8-K · May 19, 2025
- Novavax Q1 2025: Balance Sheet Shifts — 10-Q · May 8, 2025
- Novavax Enters Material Definitive Agreement — 8-K · May 5, 2025
- Novavax Files Definitive Proxy Statement — DEFA14A · Apr 30, 2025
- Novavax Announces Executive and Director Compensation Changes — 8-K · Apr 29, 2025
- Novavax DEF 14A: Executive Compensation Details — DEF 14A · Apr 29, 2025
- Novavax Files 8-K: Regulation FD Disclosure — 8-K · Apr 23, 2025
- Novavax Files 8-K for Regulation FD Disclosure — 8-K · Apr 2, 2025
- Novavax Terminates Material Definitive Agreement — 8-K · Mar 11, 2025
- Novavax Files 8-K Report — 8-K · Mar 4, 2025
- Novavax Inc. Files 2024 Annual Report — 10-K · Feb 27, 2025
- Novavax Files 8-K on Financials — 8-K · Jan 13, 2025